Evidence map›Paper›PMID 25010664›Full record

ArticlePloS one2014

Genetic variation in DNA repair pathways and risk of non-Hodgkin's lymphoma.

Justin Rendleman, Yevgeniy Antipin, Boris Reva, Christina Adaniel, Jennifer A Przybylo, Ana Dutra-Clarke, Nichole Hansen, Adriana Heguy, Kety Huberman, Laetitia Borsu and 12 more

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed
1.0field-weighted citation impact, top 25% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed, 24 citations in OpenAlex.

  1. Detection of radiosensitive subpopulationsFrontiers in oncology · 2025
    Article
  2. Clinical Risks for Chronic Lymphocytic Leukemia.Journal of the National Comprehensive Cancer Network : JNCCN · 2024
    Review
  3. Article
  4. Rare GermlineJournal of clinical oncology : official journal of the American Society of Clinical Oncology · 2023
    Article
  5. Article
  6. Article
  7. Article
  8. Review
  9. Review
  10. Article
  11. Article
  12. Review
  13. Ataxia Telangiectasia-Mutated (Frontiers in public health · 2017
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

22 authors at 4 institutions in 2 countries.

Justin RendlemanNYU School of Medicine, New York University, New York, New York, United States of America.
Yevgeniy AntipinMemorial Sloan-Kettering Cancer Center, New York, New York, United States of America.
Boris RevaMemorial Sloan-Kettering Cancer Center, New York, New York, United States of America.
Christina AdanielNYU School of Medicine, New York University, New York, New York, United States of America.
Jennifer A PrzybyloMemorial Sloan-Kettering Cancer Center, New York, New York, United States of America.
Ana Dutra-ClarkeMemorial Sloan-Kettering Cancer Center, New York, New York, United States of America.
Nichole HansenMemorial Sloan-Kettering Cancer Center, New York, New York, United States of America.
Adriana HeguyMemorial Sloan-Kettering Cancer Center, New York, New York, United States of America.
Kety HubermanMemorial Sloan-Kettering Cancer Center, New York, New York, United States of America.
Laetitia BorsuMemorial Sloan-Kettering Cancer Center, New York, New York, United States of America.
Ora PaltielHadassah-Hebrew University Medical Center, Jerusalem, Israel.
Dina Ben-YehudaHadassah-Hebrew University Medical Center, Jerusalem, Israel.
Jennifer R BrownDana Farber Cancer Center, Harvard University, Boston, Massachusetts, United States of America.
Arnold S FreedmanDana Farber Cancer Center, Harvard University, Boston, Massachusetts, United States of America.
Chris SanderMemorial Sloan-Kettering Cancer Center, New York, New York, United States of America.
Andrew ZelenetzMemorial Sloan-Kettering Cancer Center, New York, New York, United States of America.
Robert J KleinMemorial Sloan-Kettering Cancer Center, New York, New York, United States of America.
Yongzhao ShaoNYU School of Medicine, New York University, New York, New York, United States of America.
Mortimer LacherMemorial Sloan-Kettering Cancer Center, New York, New York, United States of America.
Joseph VijaiMemorial Sloan-Kettering Cancer Center, New York, New York, United States of America.
Kenneth OffitMemorial Sloan-Kettering Cancer Center, New York, New York, United States of America.
Tomas KirchhoffNYU School of Medicine, New York University, New York, New York, United States of America.
Memorial Sloan Kettering Cancer Center · USNew York University · USHadassah Medical Center · ILHarvard University · US

Funding

X-RAY CRYSTALLOGRAPHYP30CA008748 · NCI · SLOAN-KETTERING INSTITUTE FOR CANCER RES · PI Nicholas D Socci · 1985 to 2026
$347.4M
Vaccine FacilityP30CA016087 · NCI · NEW YORK UNIVERSITY SCHOOL OF MEDICINE · PI ADRIANA HEGUY · 1985 to 2026
$83.1M
Genetic Alterations in Families with Multiple LymphomasK23CA115682 · NCI · DANA-FARBER CANCER INSTITUTE · PI BROWN, JENNIFER R · 2005 to 2009
$754k
NCI NIH HHS K23 CA115682NCI NIH HHS P30 CA008748NCI NIH HHS P30 CA016087
6 · The paper itself

Abstract

Molecular and genetic evidence suggests that DNA repair pathways may contribute to lymphoma susceptibility. Several studies have examined the association of DNA repair genes with lymphoma risk, but the findings from these reports have been inconsistent. Here we provide the results of a focused analysis of genetic variation in DNA repair genes and their association with the risk of non-Hodgkin's lymphoma (NHL). With a population of 1,297 NHL cases and 1,946 controls, we have performed a two-stage case/control association analysis of 446 single nucleotide polymorphisms (SNPs) tagging the genetic variation in 81 DNA repair genes. We found the most significant association with NHL risk in the ATM locus for rs227060 (OR = 1.27, 95% CI: 1.13-1.43, p = 6.77×10(-5)), which remained significant after adjustment for multiple testing. In a subtype-specific analysis, associations were also observed for the ATM locus among both diffuse large B-cell lymphomas (DLBCL) and small lymphocytic lymphomas (SLL), however there was no association observed among follicular lymphomas (FL). In addition, our study provides suggestive evidence of an interaction between SNPs in MRE11A and NBS1 associated with NHL risk (OR = 0.51, 95% CI: 0.34-0.77, p = 0.0002). Finally, an imputation analysis using the 1,000 Genomes Project data combined with a functional prediction analysis revealed the presence of biologically relevant variants that correlate with the observed association signals. While the findings generated here warrant independent validation, the results of our large study suggest that ATM may be a novel locus associated with the risk of multiple subtypes of NHL.

Indexed as

Polymorphism, Single NucleotideDNA RepairEpistasis, GeneticGenetic Predisposition to DiseaseGenomicsHumansLymphoma, Non-HodgkinQuantitative Trait Loci

Identifiers

PMID25010664
PMCPMC4092067
OpenAlexW2035107954

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.